

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.06926740 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.86568444 |
| 3 | vocalization behavior (GO:0071625) | 4.75004872 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56853962 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.50005679 |
| 6 | response to pheromone (GO:0019236) | 4.37200738 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.26862831 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.18143987 |
| 9 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.14708119 |
| 10 | glutamate secretion (GO:0014047) | 4.13000333 |
| 11 | long term synaptic depression (GO:0060292) | 4.11000179 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.08332647 |
| 13 | locomotory exploration behavior (GO:0035641) | 4.03264564 |
| 14 | presynaptic membrane organization (GO:0097090) | 3.95387797 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.94469315 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.83796634 |
| 17 | long-term synaptic potentiation (GO:0060291) | 3.80724072 |
| 18 | single strand break repair (GO:0000012) | 3.78988799 |
| 19 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.73988430 |
| 20 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.72228944 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.72180924 |
| 22 | protein localization to synapse (GO:0035418) | 3.68883081 |
| 23 | nucleobase catabolic process (GO:0046113) | 3.68407653 |
| 24 | neuron recognition (GO:0008038) | 3.67336976 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.64642634 |
| 26 | axonal fasciculation (GO:0007413) | 3.60943835 |
| 27 | exploration behavior (GO:0035640) | 3.59040162 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.58507531 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.54409335 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.53398752 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.52263076 |
| 32 | dendrite morphogenesis (GO:0048813) | 3.48665029 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48011021 |
| 34 | * synapse assembly (GO:0007416) | 3.47268244 |
| 35 | protein localization to cilium (GO:0061512) | 3.46388420 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.40392020 |
| 37 | neurotransmitter secretion (GO:0007269) | 3.36667266 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 3.32543262 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.30441671 |
| 40 | auditory behavior (GO:0031223) | 3.25139351 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.23733104 |
| 42 | glycerophospholipid catabolic process (GO:0046475) | 3.22936109 |
| 43 | positive regulation of neurotransmitter transport (GO:0051590) | 3.20267104 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.20154416 |
| 45 | regulation of glucocorticoid secretion (GO:2000849) | 3.19726640 |
| 46 | gamma-aminobutyric acid transport (GO:0015812) | 3.14070968 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.13298457 |
| 48 | cell migration in hindbrain (GO:0021535) | 3.12865144 |
| 49 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.11385800 |
| 50 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.11259163 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11112147 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.10663433 |
| 53 | behavioral response to nicotine (GO:0035095) | 3.10046803 |
| 54 | layer formation in cerebral cortex (GO:0021819) | 3.09165221 |
| 55 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.09059338 |
| 56 | long-term memory (GO:0007616) | 3.08948911 |
| 57 | innervation (GO:0060384) | 3.07591992 |
| 58 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07546427 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 3.07351696 |
| 60 | positive regulation of membrane potential (GO:0045838) | 3.06071476 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 3.05612395 |
| 62 | protein-chromophore linkage (GO:0018298) | 3.04438754 |
| 63 | dendrite development (GO:0016358) | 3.02096059 |
| 64 | regulation of postsynaptic membrane potential (GO:0060078) | 2.99802280 |
| 65 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.97584288 |
| 66 | neuronal action potential propagation (GO:0019227) | 2.92540504 |
| 67 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.92446882 |
| 68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.92089859 |
| 69 | negative regulation of microtubule polymerization (GO:0031115) | 2.88797717 |
| 70 | regulation of vesicle fusion (GO:0031338) | 2.88759390 |
| 71 | regulation of synapse maturation (GO:0090128) | 2.88651191 |
| 72 | regulation of neurotransmitter uptake (GO:0051580) | 2.88260845 |
| 73 | transmission of nerve impulse (GO:0019226) | 2.87962350 |
| 74 | neurotransmitter transport (GO:0006836) | 2.87774100 |
| 75 | regulation of synapse structural plasticity (GO:0051823) | 2.87237838 |
| 76 | behavioral response to cocaine (GO:0048148) | 2.86874309 |
| 77 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.86290818 |
| 78 | postsynaptic membrane organization (GO:0001941) | 2.85867426 |
| 79 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.85795276 |
| 80 | regulation of synaptic plasticity (GO:0048167) | 2.85557544 |
| 81 | cGMP-mediated signaling (GO:0019934) | 2.83739969 |
| 82 | membrane hyperpolarization (GO:0060081) | 2.83250997 |
| 83 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.82532020 |
| 84 | atrial cardiac muscle cell action potential (GO:0086014) | 2.82488070 |
| 85 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.80867130 |
| 86 | * synapse organization (GO:0050808) | 2.80416048 |
| 87 | membrane depolarization during action potential (GO:0086010) | 2.80124934 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79492869 |
| 89 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.79181413 |
| 90 | negative regulation of synaptic transmission (GO:0050805) | 2.79060768 |
| 91 | behavioral defense response (GO:0002209) | 2.78902542 |
| 92 | behavioral fear response (GO:0001662) | 2.78902542 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.78467164 |
| 94 | * calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.78385167 |
| 95 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.78019862 |
| 96 | positive regulation of synapse assembly (GO:0051965) | 2.78014949 |
| 97 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.77367174 |
| 98 | * homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.73849640 |
| 99 | negative regulation of neurotransmitter transport (GO:0051589) | 2.72666404 |
| 100 | neuronal ion channel clustering (GO:0045161) | 2.72331004 |
| 101 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72004029 |
| 102 | membrane depolarization (GO:0051899) | 2.71147342 |
| 103 | response to histamine (GO:0034776) | 2.70806319 |
| 104 | proline transport (GO:0015824) | 2.70746737 |
| 105 | presynaptic membrane assembly (GO:0097105) | 2.70428921 |
| 106 | regulation of action potential (GO:0098900) | 2.70344853 |
| 107 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.70074409 |
| 108 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.67871292 |
| 109 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.67847292 |
| 110 | cochlea development (GO:0090102) | 2.67458870 |
| 111 | establishment of mitochondrion localization (GO:0051654) | 2.67226327 |
| 112 | activation of protein kinase A activity (GO:0034199) | 2.66644923 |
| 113 | learning (GO:0007612) | 2.65673460 |
| 114 | regulation of neurotransmitter levels (GO:0001505) | 2.64678863 |
| 115 | negative regulation of complement activation (GO:0045916) | 2.63876233 |
| 116 | fear response (GO:0042596) | 2.63256132 |
| 117 | * synaptic transmission (GO:0007268) | 2.63130639 |
| 118 | mechanosensory behavior (GO:0007638) | 2.63120496 |
| 119 | positive regulation of dendritic spine development (GO:0060999) | 2.60941221 |
| 120 | positive regulation of action potential (GO:0045760) | 2.55410343 |
| 121 | regulation of neurotransmitter transport (GO:0051588) | 2.54332324 |
| 122 | multicellular organismal signaling (GO:0035637) | 2.52888781 |
| 123 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.52333956 |
| 124 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.52333956 |
| 125 | potassium ion homeostasis (GO:0055075) | 2.52293537 |
| 126 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.52137014 |
| 127 | nonmotile primary cilium assembly (GO:0035058) | 2.50162884 |
| 128 | glycosphingolipid biosynthetic process (GO:0006688) | 2.50064920 |
| 129 | neuromuscular synaptic transmission (GO:0007274) | 2.49873919 |
| 130 | retinal ganglion cell axon guidance (GO:0031290) | 2.48514825 |
| 131 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.47408483 |
| 132 | short-term memory (GO:0007614) | 2.47340321 |
| 133 | alanine transport (GO:0032328) | 2.47203701 |
| 134 | neuron maturation (GO:0042551) | 2.46299007 |
| 135 | regulation of respiratory system process (GO:0044065) | 2.46183278 |
| 136 | potassium ion import (GO:0010107) | 2.45571540 |
| 137 | dopamine biosynthetic process (GO:0042416) | 2.44894949 |
| 138 | regulation of membrane repolarization (GO:0060306) | 2.44390970 |
| 139 | calcium ion import (GO:0070509) | 2.43867446 |
| 140 | positive regulation of amine transport (GO:0051954) | 2.42069591 |
| 141 | cerebellar Purkinje cell layer development (GO:0021680) | 2.41781690 |
| 142 | behavioral response to ethanol (GO:0048149) | 2.41661438 |
| 143 | regulation of neurotransmitter secretion (GO:0046928) | 2.40816490 |
| 144 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.37781253 |
| 145 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.37781253 |
| 146 | detection of calcium ion (GO:0005513) | 2.36823306 |
| 147 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.36622696 |
| 148 | phasic smooth muscle contraction (GO:0014821) | 2.35846543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.50594366 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01506619 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18343387 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97492095 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88359727 |
| 6 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.70108090 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59500555 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59135110 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55933452 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55933452 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.55474227 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47800596 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45730106 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45316140 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43682193 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40794425 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37700128 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.28465002 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17430461 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14435176 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14202038 |
| 22 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.06276906 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01607500 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96188342 |
| 25 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.94442518 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90863809 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90813218 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88954645 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88490064 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86754600 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.78264664 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68361109 |
| 33 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.65972502 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61814481 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59849269 |
| 36 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.59635193 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.58063984 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57689276 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56967557 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56056243 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55675356 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54764986 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53304726 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53297446 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.52602584 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52451554 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46674106 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44439899 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43225318 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42994243 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42813680 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40824942 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40750139 |
| 54 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36029886 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35000005 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34534005 |
| 57 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.34072182 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33247109 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32189250 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29513941 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27509864 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25396866 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24185341 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23254957 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21948597 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21427681 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20343973 |
| 68 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19336136 |
| 69 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18234860 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17334772 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17253087 |
| 72 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14714149 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14629970 |
| 74 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14160461 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13445995 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12535086 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12535086 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11966744 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11477358 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11023521 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10044653 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09763310 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09052564 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09052564 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08633723 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08486456 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08183419 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07192672 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07055951 |
| 90 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06601504 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06066517 |
| 92 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05652852 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05345515 |
| 94 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04909768 |
| 95 | AR_19668381_ChIP-Seq_PC3_Human | 1.04580760 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04417655 |
| 97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03569046 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03332902 |
| 99 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03186864 |
| 100 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02865181 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02304327 |
| 102 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01997646 |
| 103 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01889782 |
| 104 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01774798 |
| 105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99965579 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99841835 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98863692 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98638098 |
| 109 | JUN_21703547_ChIP-Seq_K562_Human | 0.98265825 |
| 110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97847797 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97026790 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95460999 |
| 113 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94842120 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93960578 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93845028 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93845028 |
| 117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92980687 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92454742 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92363259 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91885146 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91496383 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91132997 |
| 123 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.90412798 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89086660 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87113963 |
| 126 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86893207 |
| 127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86761256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.46169638 |
| 2 | MP0003880_abnormal_central_pattern | 4.12339213 |
| 3 | MP0002736_abnormal_nociception_after | 3.54806437 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.45731070 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.40548023 |
| 6 | MP0004270_analgesia | 3.24048602 |
| 7 | MP0002638_abnormal_pupillary_reflex | 3.02320982 |
| 8 | MP0009745_abnormal_behavioral_response | 2.77209486 |
| 9 | MP0002064_seizures | 2.61254787 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.59361677 |
| 11 | MP0009046_muscle_twitch | 2.55467462 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.46911632 |
| 13 | MP0001486_abnormal_startle_reflex | 2.44738216 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.17458192 |
| 15 | MP0001529_abnormal_vocalization | 2.15235292 |
| 16 | MP0002822_catalepsy | 2.13295458 |
| 17 | MP0002272_abnormal_nervous_system | 2.10645091 |
| 18 | MP0004858_abnormal_nervous_system | 2.01897628 |
| 19 | MP0001502_abnormal_circadian_rhythm | 1.97188354 |
| 20 | MP0000778_abnormal_nervous_system | 1.96287558 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.88233380 |
| 22 | MP0002184_abnormal_innervation | 1.87631068 |
| 23 | MP0005423_abnormal_somatic_nervous | 1.87351750 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.86884288 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 1.80718819 |
| 26 | MP0004924_abnormal_behavior | 1.75367410 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.75367410 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.75214424 |
| 29 | MP0004885_abnormal_endolymph | 1.74741315 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.73068724 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.72079324 |
| 32 | MP0008569_lethality_at_weaning | 1.70238195 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.67543502 |
| 34 | MP0001970_abnormal_pain_threshold | 1.63099036 |
| 35 | MP0001188_hyperpigmentation | 1.58431906 |
| 36 | MP0004233_abnormal_muscle_weight | 1.57404746 |
| 37 | MP0004133_heterotaxia | 1.54717094 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.54545979 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.53951381 |
| 40 | MP0000955_abnormal_spinal_cord | 1.39940140 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.39099692 |
| 42 | MP0004142_abnormal_muscle_tone | 1.38877928 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.35981207 |
| 44 | MP0005409_darkened_coat_color | 1.35351586 |
| 45 | MP0003879_abnormal_hair_cell | 1.34524915 |
| 46 | MP0001905_abnormal_dopamine_level | 1.33429610 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.33150526 |
| 48 | MP0003787_abnormal_imprinting | 1.30918222 |
| 49 | MP0000751_myopathy | 1.28882893 |
| 50 | MP0002090_abnormal_vision | 1.28329262 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.26291246 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.25117739 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.24387596 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.22429399 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.21369150 |
| 56 | MP0001944_abnormal_pancreas_morphology | 1.19813081 |
| 57 | MP0001984_abnormal_olfaction | 1.17766468 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.16564770 |
| 59 | MP0003690_abnormal_glial_cell | 1.13594736 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.13092303 |
| 61 | MP0004742_abnormal_vestibular_system | 1.11889065 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.11184231 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.10521626 |
| 64 | MP0005499_abnormal_olfactory_system | 1.09295370 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.09295370 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.08096485 |
| 67 | MP0009384_cardiac_valve_regurgitation | 1.05358530 |
| 68 | MP0006292_abnormal_olfactory_placode | 1.04880590 |
| 69 | MP0003121_genomic_imprinting | 1.03776837 |
| 70 | MP0003329_amyloid_beta_deposits | 1.03397236 |
| 71 | MP0005171_absent_coat_pigmentation | 1.03138462 |
| 72 | MP0002938_white_spotting | 1.03050391 |
| 73 | MP0001849_ear_inflammation | 1.02168153 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 1.01515811 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 1.01410265 |
| 76 | MP0003633_abnormal_nervous_system | 1.01324273 |
| 77 | MP0002752_abnormal_somatic_nervous | 1.00794503 |
| 78 | MP0004085_abnormal_heartbeat | 0.99747692 |
| 79 | MP0002152_abnormal_brain_morphology | 0.98379684 |
| 80 | MP0002229_neurodegeneration | 0.96481087 |
| 81 | MP0005253_abnormal_eye_physiology | 0.96222941 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 0.95590327 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.94951272 |
| 84 | MP0000569_abnormal_digit_pigmentation | 0.94854868 |
| 85 | MP0004043_abnormal_pH_regulation | 0.94341066 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.93881151 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.93245369 |
| 88 | MP0001485_abnormal_pinna_reflex | 0.92917870 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.92762151 |
| 90 | MP0003631_nervous_system_phenotype | 0.92711862 |
| 91 | MP0003634_abnormal_glial_cell | 0.91156787 |
| 92 | MP0003045_fibrosis | 0.90810649 |
| 93 | MP0002163_abnormal_gland_morphology | 0.89116342 |
| 94 | MP0008872_abnormal_physiological_respon | 0.88592972 |
| 95 | MP0004147_increased_porphyrin_level | 0.87932773 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.85432215 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.84527801 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.84063170 |
| 99 | MP0000920_abnormal_myelination | 0.83865046 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.83416544 |
| 101 | MP0005248_abnormal_Harderian_gland | 0.83020553 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.82446534 |
| 103 | MP0003122_maternal_imprinting | 0.81949560 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.80984029 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.79772311 |
| 106 | MP0001756_abnormal_urination | 0.78213147 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.76838349 |
| 108 | MP0005195_abnormal_posterior_eye | 0.76247028 |
| 109 | MP0003011_delayed_dark_adaptation | 0.76220727 |
| 110 | MP0001177_atelectasis | 0.76175167 |
| 111 | MP0005187_abnormal_penis_morphology | 0.75092509 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.73956075 |
| 113 | MP0003632_abnormal_nervous_system | 0.72933299 |
| 114 | MP0003195_calcinosis | 0.71605248 |
| 115 | MP0005448_abnormal_energy_balance | 0.71045834 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.71014686 |
| 117 | MP0004130_abnormal_muscle_cell | 0.69069774 |
| 118 | MP0000026_abnormal_inner_ear | 0.68522382 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 0.68470457 |
| 120 | MP0001270_distended_abdomen | 0.66680030 |
| 121 | MP0004484_altered_response_of | 0.65250748 |
| 122 | MP0008874_decreased_physiological_sensi | 0.60447627 |
| 123 | MP0003861_abnormal_nervous_system | 0.60054485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.34562512 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.24576734 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.03048683 |
| 4 | Focal seizures (HP:0007359) | 4.57228600 |
| 5 | Visual hallucinations (HP:0002367) | 4.54930701 |
| 6 | Myokymia (HP:0002411) | 4.50443618 |
| 7 | Enlarged kidneys (HP:0000105) | 4.09407546 |
| 8 | Blue irides (HP:0000635) | 3.90988907 |
| 9 | Action tremor (HP:0002345) | 3.70393829 |
| 10 | Febrile seizures (HP:0002373) | 3.66575025 |
| 11 | Atonic seizures (HP:0010819) | 3.60439936 |
| 12 | Progressive inability to walk (HP:0002505) | 3.58731967 |
| 13 | Hemiparesis (HP:0001269) | 3.48109349 |
| 14 | Double outlet right ventricle (HP:0001719) | 3.47590816 |
| 15 | Congenital malformation of the right heart (HP:0011723) | 3.47590816 |
| 16 | Absence seizures (HP:0002121) | 3.45575009 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.30032088 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.29992725 |
| 19 | Intestinal atresia (HP:0011100) | 3.27887124 |
| 20 | Hyperventilation (HP:0002883) | 3.20695255 |
| 21 | Mutism (HP:0002300) | 3.19784698 |
| 22 | Central scotoma (HP:0000603) | 3.09001183 |
| 23 | Scotoma (HP:0000575) | 3.02693624 |
| 24 | Dialeptic seizures (HP:0011146) | 3.00602188 |
| 25 | True hermaphroditism (HP:0010459) | 3.00046634 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.98190609 |
| 27 | Agitation (HP:0000713) | 2.93530882 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 2.91878677 |
| 29 | EEG with generalized epileptiform discharges (HP:0011198) | 2.85188927 |
| 30 | Broad-based gait (HP:0002136) | 2.79221861 |
| 31 | Pheochromocytoma (HP:0002666) | 2.76333408 |
| 32 | Limb dystonia (HP:0002451) | 2.76215949 |
| 33 | Pancreatic cysts (HP:0001737) | 2.70742921 |
| 34 | Hypothermia (HP:0002045) | 2.70214790 |
| 35 | Amblyopia (HP:0000646) | 2.64500680 |
| 36 | Anxiety (HP:0000739) | 2.62668620 |
| 37 | Hypsarrhythmia (HP:0002521) | 2.60858554 |
| 38 | Poor eye contact (HP:0000817) | 2.58082099 |
| 39 | Medial flaring of the eyebrow (HP:0010747) | 2.55931728 |
| 40 | Nephronophthisis (HP:0000090) | 2.55899400 |
| 41 | Dysmetria (HP:0001310) | 2.54270665 |
| 42 | Fetal akinesia sequence (HP:0001989) | 2.50240268 |
| 43 | Type II lissencephaly (HP:0007260) | 2.49605454 |
| 44 | Ankle clonus (HP:0011448) | 2.47946744 |
| 45 | Depression (HP:0000716) | 2.47726316 |
| 46 | Congenital sensorineural hearing impairment (HP:0008527) | 2.46802641 |
| 47 | Drooling (HP:0002307) | 2.45437223 |
| 48 | Excessive salivation (HP:0003781) | 2.45437223 |
| 49 | Poor coordination (HP:0002370) | 2.39659670 |
| 50 | Aortic valve stenosis (HP:0001650) | 2.39198600 |
| 51 | Delayed gross motor development (HP:0002194) | 2.38292600 |
| 52 | Impaired social interactions (HP:0000735) | 2.38161566 |
| 53 | Abnormal social behavior (HP:0012433) | 2.38161566 |
| 54 | Cerebral hypomyelination (HP:0006808) | 2.38101733 |
| 55 | Intention tremor (HP:0002080) | 2.37968057 |
| 56 | Retinal dysplasia (HP:0007973) | 2.34533633 |
| 57 | Esophageal atresia (HP:0002032) | 2.33178813 |
| 58 | Truncal ataxia (HP:0002078) | 2.32871340 |
| 59 | Inability to walk (HP:0002540) | 2.32845813 |
| 60 | Gait imbalance (HP:0002141) | 2.31726111 |
| 61 | Exotropia (HP:0000577) | 2.30428418 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.29181267 |
| 63 | Hypoventilation (HP:0002791) | 2.29067136 |
| 64 | Pulmonic stenosis (HP:0001642) | 2.28978666 |
| 65 | Termporal pattern (HP:0011008) | 2.26639280 |
| 66 | Insidious onset (HP:0003587) | 2.26639280 |
| 67 | Nephrogenic diabetes insipidus (HP:0009806) | 2.26223751 |
| 68 | Severe Myopia (HP:0011003) | 2.25777157 |
| 69 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24429109 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.22081341 |
| 71 | Methylmalonic acidemia (HP:0002912) | 2.21766318 |
| 72 | Abnormal eating behavior (HP:0100738) | 2.20607593 |
| 73 | Genetic anticipation (HP:0003743) | 2.19737939 |
| 74 | Absent speech (HP:0001344) | 2.19641868 |
| 75 | Large for gestational age (HP:0001520) | 2.18933260 |
| 76 | Prominent supraorbital ridges (HP:0000336) | 2.18827157 |
| 77 | Abnormality of the renal medulla (HP:0100957) | 2.16196742 |
| 78 | Polydipsia (HP:0001959) | 2.16157053 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.16157053 |
| 80 | Spastic gait (HP:0002064) | 2.13120982 |
| 81 | Abnormal EKG (HP:0003115) | 2.12949173 |
| 82 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.12563442 |
| 83 | Hypoplasia of the brainstem (HP:0002365) | 2.12563442 |
| 84 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11788875 |
| 85 | Torticollis (HP:0000473) | 2.07664431 |
| 86 | Hyperthyroidism (HP:0000836) | 2.07592879 |
| 87 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.07041536 |
| 88 | Cystic liver disease (HP:0006706) | 2.05240385 |
| 89 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03816523 |
| 90 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03816523 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.03636802 |
| 92 | Molar tooth sign on MRI (HP:0002419) | 2.02971916 |
| 93 | Abnormality of midbrain morphology (HP:0002418) | 2.02971916 |
| 94 | Polyphagia (HP:0002591) | 2.02041455 |
| 95 | Prolonged QT interval (HP:0001657) | 2.01322294 |
| 96 | Cerebral inclusion bodies (HP:0100314) | 2.01078241 |
| 97 | Sleep apnea (HP:0010535) | 2.00466580 |
| 98 | Bundle branch block (HP:0011710) | 1.99183620 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 1.99035744 |
| 100 | Increased CSF protein (HP:0002922) | 1.96867914 |
| 101 | Spastic tetraplegia (HP:0002510) | 1.94562487 |
| 102 | Horizontal nystagmus (HP:0000666) | 1.93211371 |
| 103 | Atelectasis (HP:0100750) | 1.93035648 |
| 104 | Poor suck (HP:0002033) | 1.92950159 |
| 105 | Failure to thrive in infancy (HP:0001531) | 1.92882013 |
| 106 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92808802 |
| 107 | Occipital encephalocele (HP:0002085) | 1.92364806 |
| 108 | Abnormality of the renal cortex (HP:0011035) | 1.92336486 |
| 109 | Inappropriate behavior (HP:0000719) | 1.91398079 |
| 110 | Abnormality of macular pigmentation (HP:0008002) | 1.91210047 |
| 111 | Postural tremor (HP:0002174) | 1.90909920 |
| 112 | Gaze-evoked nystagmus (HP:0000640) | 1.90159232 |
| 113 | Delusions (HP:0000746) | 1.89866626 |
| 114 | Lissencephaly (HP:0001339) | 1.89532929 |
| 115 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.86854095 |
| 116 | Muscular hypotonia of the trunk (HP:0008936) | 1.85681596 |
| 117 | Choroideremia (HP:0001139) | 1.84957266 |
| 118 | Specific learning disability (HP:0001328) | 1.84154545 |
| 119 | Palpebral edema (HP:0100540) | 1.83957846 |
| 120 | Furrowed tongue (HP:0000221) | 1.83664322 |
| 121 | Growth hormone deficiency (HP:0000824) | 1.82523477 |
| 122 | Papilledema (HP:0001085) | 1.82430069 |
| 123 | Congenital primary aphakia (HP:0007707) | 1.82325059 |
| 124 | Abnormality of the corticospinal tract (HP:0002492) | 1.80614223 |
| 125 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80275645 |
| 126 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80275645 |
| 127 | Incomplete penetrance (HP:0003829) | 1.77698581 |
| 128 | Abnormality of salivation (HP:0100755) | 1.77635323 |
| 129 | Postural instability (HP:0002172) | 1.75958497 |
| 130 | Metaphyseal dysplasia (HP:0100255) | 1.75852545 |
| 131 | Genital tract atresia (HP:0001827) | 1.75534767 |
| 132 | Pachygyria (HP:0001302) | 1.74417255 |
| 133 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.73212408 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.72033855 |
| 135 | Lower limb muscle weakness (HP:0007340) | 1.71947245 |
| 136 | Heterochromia iridis (HP:0001100) | 1.71705007 |
| 137 | Sclerocornea (HP:0000647) | 1.71438673 |
| 138 | Syncope (HP:0001279) | 1.71370412 |
| 139 | Lower limb amyotrophy (HP:0007210) | 1.70762388 |
| 140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.70244072 |
| 141 | Abnormal pancreas size (HP:0012094) | 1.69792783 |
| 142 | 3-Methylglutaconic aciduria (HP:0003535) | 1.69770049 |
| 143 | Glycosuria (HP:0003076) | 1.69728838 |
| 144 | Abnormality of urine glucose concentration (HP:0011016) | 1.69728838 |
| 145 | Left ventricular hypertrophy (HP:0001712) | 1.69336715 |
| 146 | Aqueductal stenosis (HP:0002410) | 1.69035720 |
| 147 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68278625 |
| 148 | Impaired smooth pursuit (HP:0007772) | 1.66831076 |
| 149 | Generalized myoclonic seizures (HP:0002123) | 1.66318994 |
| 150 | Focal dystonia (HP:0004373) | 1.66296983 |
| 151 | Abnormality of vitamin metabolism (HP:0100508) | 1.66248301 |
| 152 | Optic nerve hypoplasia (HP:0000609) | 1.65962140 |
| 153 | Akinesia (HP:0002304) | 1.65498881 |
| 154 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.65162637 |
| 155 | Hemiplegia (HP:0002301) | 1.65136100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR2 | 4.58975006 |
| 2 | MARK1 | 4.20327722 |
| 3 | NTRK2 | 4.01757070 |
| 4 | TYRO3 | 3.85638397 |
| 5 | FGFR4 | 3.04399287 |
| 6 | NTRK3 | 2.85111839 |
| 7 | FRK | 2.79548215 |
| 8 | EPHA3 | 2.74658882 |
| 9 | EPHA4 | 2.57633242 |
| 10 | MINK1 | 2.40124132 |
| 11 | WNK3 | 2.36684028 |
| 12 | MAP4K2 | 2.35339716 |
| 13 | PDGFRA | 2.11114004 |
| 14 | MAP3K10 | 2.08937285 |
| 15 | MAP3K9 | 1.93373950 |
| 16 | GRK1 | 1.92282709 |
| 17 | MAP3K4 | 1.90554271 |
| 18 | MAP2K7 | 1.86244689 |
| 19 | PAK6 | 1.81307752 |
| 20 | CAMK2B | 1.81261638 |
| 21 | CASK | 1.77868983 |
| 22 | GRK7 | 1.76314051 |
| 23 | DAPK2 | 1.47377100 |
| 24 | DYRK1A | 1.47114014 |
| 25 | WNK4 | 1.44769462 |
| 26 | NTRK1 | 1.43675285 |
| 27 | SIK3 | 1.41718886 |
| 28 | FGFR3 | 1.40131560 |
| 29 | NME1 | 1.39372995 |
| 30 | ADRBK2 | 1.28756206 |
| 31 | SGK2 | 1.25708009 |
| 32 | PRPF4B | 1.24687888 |
| 33 | FES | 1.19984833 |
| 34 | RET | 1.19771969 |
| 35 | MAPK13 | 1.19312354 |
| 36 | CAMK2A | 1.18854728 |
| 37 | CAMK2D | 1.18233390 |
| 38 | CAMK2G | 1.17252906 |
| 39 | CDK5 | 1.14399482 |
| 40 | KSR1 | 1.13674611 |
| 41 | UHMK1 | 1.08814016 |
| 42 | LATS2 | 1.06457197 |
| 43 | MAP3K11 | 1.06248498 |
| 44 | MAP2K4 | 1.03503299 |
| 45 | RIPK4 | 1.02456397 |
| 46 | DDR2 | 0.99933443 |
| 47 | TNIK | 0.99598820 |
| 48 | PNCK | 0.99194127 |
| 49 | STK38L | 0.98056152 |
| 50 | PINK1 | 0.97897311 |
| 51 | PDK3 | 0.95967464 |
| 52 | PDK4 | 0.95967464 |
| 53 | TRIM28 | 0.95509782 |
| 54 | PHKG2 | 0.92860827 |
| 55 | PHKG1 | 0.92860827 |
| 56 | TIE1 | 0.88267156 |
| 57 | YES1 | 0.86958272 |
| 58 | STK38 | 0.85964338 |
| 59 | MAP3K12 | 0.85324869 |
| 60 | AKT3 | 0.84132065 |
| 61 | CDK19 | 0.81912643 |
| 62 | SGK1 | 0.79739894 |
| 63 | BCR | 0.76293261 |
| 64 | OXSR1 | 0.74616534 |
| 65 | PRKCG | 0.74493177 |
| 66 | PTK2B | 0.74182726 |
| 67 | KSR2 | 0.73408706 |
| 68 | CSNK1G2 | 0.72893439 |
| 69 | PLK2 | 0.72748634 |
| 70 | CDK18 | 0.72611222 |
| 71 | WNK1 | 0.71363857 |
| 72 | LIMK1 | 0.70801121 |
| 73 | CAMKK2 | 0.69591411 |
| 74 | SGK3 | 0.69241662 |
| 75 | MKNK2 | 0.68681263 |
| 76 | PRKCH | 0.68274546 |
| 77 | CDK14 | 0.68090307 |
| 78 | STK39 | 0.66927514 |
| 79 | NLK | 0.66724517 |
| 80 | STK11 | 0.66389922 |
| 81 | INSRR | 0.66313825 |
| 82 | CDK15 | 0.65515958 |
| 83 | MAPKAPK5 | 0.62910166 |
| 84 | GRK5 | 0.62832043 |
| 85 | FER | 0.62197954 |
| 86 | PAK3 | 0.59306432 |
| 87 | MAP2K6 | 0.56243937 |
| 88 | CAMKK1 | 0.55306555 |
| 89 | FGFR1 | 0.55298563 |
| 90 | PDGFRB | 0.53962834 |
| 91 | TRIB3 | 0.53753874 |
| 92 | PRKG1 | 0.52876031 |
| 93 | PRKCI | 0.52512401 |
| 94 | PKN1 | 0.52114652 |
| 95 | CDK11A | 0.51726516 |
| 96 | TAOK1 | 0.51572254 |
| 97 | SGK494 | 0.51449756 |
| 98 | SGK223 | 0.51449756 |
| 99 | OBSCN | 0.50970621 |
| 100 | ERBB3 | 0.50722704 |
| 101 | DAPK1 | 0.48988271 |
| 102 | PDPK1 | 0.48898577 |
| 103 | CAMK1 | 0.48737700 |
| 104 | ADRBK1 | 0.48647697 |
| 105 | CAMK1G | 0.48513888 |
| 106 | CSNK1G1 | 0.47835186 |
| 107 | PRKD3 | 0.47811714 |
| 108 | BMPR1B | 0.47197980 |
| 109 | PRKCE | 0.46570450 |
| 110 | PRKCZ | 0.46423885 |
| 111 | CSNK1A1 | 0.44863090 |
| 112 | FGR | 0.44576977 |
| 113 | DYRK3 | 0.44475873 |
| 114 | ROCK2 | 0.44204291 |
| 115 | PRKAA1 | 0.43796122 |
| 116 | PRKACB | 0.43786594 |
| 117 | PDK1 | 0.43571252 |
| 118 | DYRK2 | 0.43095530 |
| 119 | SRPK1 | 0.42745837 |
| 120 | CSNK1G3 | 0.42063302 |
| 121 | PRKD1 | 0.40888940 |
| 122 | ITK | 0.40860834 |
| 123 | MAPK15 | 0.40285335 |
| 124 | EPHB1 | 0.40245878 |
| 125 | PDK2 | 0.39576411 |
| 126 | SIK2 | 0.39418482 |
| 127 | SIK1 | 0.38129330 |
| 128 | IRAK2 | 0.37708740 |
| 129 | TNK2 | 0.37061561 |
| 130 | CAMK4 | 0.36760721 |
| 131 | CSNK1E | 0.36518378 |
| 132 | RPS6KA3 | 0.36018137 |
| 133 | PRKACA | 0.35752612 |
| 134 | ERBB2 | 0.35083376 |
| 135 | MAP2K1 | 0.34931991 |
| 136 | CSNK1D | 0.33896532 |
| 137 | FYN | 0.33365035 |
| 138 | EPHB2 | 0.32307142 |
| 139 | CSNK1A1L | 0.32284173 |
| 140 | PRKCA | 0.31548229 |
| 141 | MAP3K2 | 0.26612864 |
| 142 | MAP3K5 | 0.26133436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.56962624 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.06529519 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68182553 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.65359816 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64502136 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42581436 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.39924333 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22767810 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.11719187 |
| 10 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.10239422 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.00759226 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98198355 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.96940627 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.96038581 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.90533977 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.83487852 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.76605177 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.71154498 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66064794 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65248617 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.64197034 |
| 22 | Axon guidance_Homo sapiens_hsa04360 | 1.64160334 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57027529 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56718957 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53373211 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.48135418 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46734771 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44468678 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41380558 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.41354742 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41140747 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36749074 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.33633089 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31680165 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.29184565 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29047740 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.28944458 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27428327 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26961836 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19401345 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17313622 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15247306 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13480003 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13353288 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11377356 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11223316 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.09683387 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09250399 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08861187 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07757943 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07554341 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04125699 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04051085 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03637829 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02524829 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01387013 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92360573 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.92264047 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.92010916 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91904033 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90966713 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90143722 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88100671 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87184043 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85372314 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83887015 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82722869 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82682783 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82151676 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82023585 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80795481 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80018871 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79430519 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77775370 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76654732 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75800270 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75502900 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75092533 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74303254 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73476107 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71752170 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70373088 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70124164 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68567714 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66440677 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65909918 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65048870 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64512605 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63542478 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63033000 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62745089 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59390687 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.58987649 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57737056 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56844233 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56644833 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.56572541 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53776260 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.53262550 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52846336 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52173633 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50687467 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49917102 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49817225 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48335104 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47895703 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.47806014 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46739496 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46506662 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44449352 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.43795377 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43773765 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.43584990 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.42990226 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42843149 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42705352 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40475557 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39271258 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37682683 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37295640 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36609824 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36117795 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35524180 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33469060 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31651171 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31435227 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31368437 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30382351 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29662740 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28177475 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28137146 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.28096424 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.27680321 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.27077842 |

